Company intelligence / Profile preview

SINTEF

Ownership: Private
Employees: ~2200
Development stage: Other

Overview

SINTEF does not have its own clinical results or drug pipeline but provides advanced contract research and innovation services to industry partners across life sciences and healthcare.

Therapeutic areas: Other
Modalities: Nanomedicine (including nanoparticles)Biologic (broad research in biotechnology)Device (medical devices and diagnostics)Small molecule (applied chemistry/biotech research)Recombinant protein (biotechnology applications)
Industry: Academic Hospital/University/Research

Partnerships

Extensive collaborations with Norwegian University of Science and Technology (NTNU)industry clients globallySpecific pharma/biotech partnerships are project-based

Beyond the preview

Go deeper on SINTEF.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SINTEF.

Explore the full profile